PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 2.92M (Avg.)
-0.48 | -4.19
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
66.07%
Positive EBIT growth while ACB.TO is negative. John Neff might see a substantial edge in operational management.
66.07%
Positive operating income growth while ACB.TO is negative. John Neff might view this as a competitive edge in operations.
71.07%
Positive net income growth while ACB.TO is negative. John Neff might see a big relative performance advantage.
71.05%
Positive EPS growth while ACB.TO is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
71.05%
Positive diluted EPS growth while ACB.TO is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-0.38%
Share reduction while ACB.TO is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.38%
Reduced diluted shares while ACB.TO is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
46.07%
Positive OCF growth while ACB.TO is negative. John Neff would see this as a clear operational advantage vs. the competitor.
46.07%
Positive FCF growth while ACB.TO is negative. John Neff would see a strong competitive edge in net cash generation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-264.77%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-264.77%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-264.77%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
78.58%
Positive 10Y CAGR while ACB.TO is negative. John Neff might see a substantial advantage in bottom-line trajectory.
78.58%
Positive 5Y CAGR while ACB.TO is negative. John Neff might view this as a strong mid-term relative advantage.
78.58%
Positive short-term CAGR while ACB.TO is negative. John Neff would see a clear advantage in near-term profit trajectory.
-13.10%
Both are negative. Martin Whitman suspects the segment is in decline or saddled with persistent unprofitability or write-downs.
-13.10%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-13.10%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-62.75%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
No Data
No Data available this quarter, please select a different quarter.
-5.84%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-1.56%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-66.07%
We cut SG&A while ACB.TO invests at 2.82%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.